Dafna Capital Management LLC Bluebird Bio, Inc. Transaction History

Dafna Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$16.59 - $33.89 $502,229 - $1.03 Million	-30,273 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.12 - $45.97 $129,443 - $219,414	4,773 Added 18.72%	30,273 $1.85 Million
Q2 2019 Aug 14, 2019	SELL	$75.84 - $105.21 $113,760 - $157,815	-1,500 Reduced 5.56%	25,500 $3.24 Million
Q4 2018 Feb 14, 2019	BUY	$59.1 - $93.26 $384,150 - $606,190	6,500 Added 31.71%	27,000 $2.68 Million
Q3 2018 Nov 14, 2018	BUY	$88.86 - $117.49 $1.47 Million - $1.94 Million	16,500 Added 412.5%	20,500 $2.99 Million
Q2 2018 Aug 13, 2018	BUY	$99.64 - $127.59 $398,560 - $510,360	4,000 New	4,000 $628,000
Q1 2018 May 15, 2018	SELL	$105.8 - $150.94 $211,600 - $301,880	-2,000 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$81.25 - $130.7 $203,125 - $326,750	-2,500 Reduced 55.56%	2,000 $356,000
Q3 2017 Nov 14, 2017	BUY	$57.74 - $91.42 $259,830 - $411,390	4,500	4,500 $618,000

142

63.2M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $605M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dafna Capital Management LLC with notifications on news.